Romsey, United Kingdom

Christopher Plummer


 

 

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 25(Granted Patents)


Location History:

  • Cambridge, GB (2012 - 2017)
  • Romsey, GB (2015 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Christopher Plummer: Innovator in Immunological Therapeutics

Introduction

Christopher Plummer is a distinguished inventor residing in Romsey, GB. With a remarkable portfolio, he holds seven patents, showcasing his contribution to the field of immunology. As an inventor, Plummer has made significant strides in developing therapeutic strategies that target immune responses.

Latest Patents

Plummer’s latest patents focus on "Compositions monovalent for CD28 binding and methods of use". These patents disclose domain antibodies that can monovalently bind to CD28, offering a novel approach to inhibiting CD28 activity. The domain antibodies consist of, or comprise, a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28 without substantially agonizing its function. Additionally, these patents include methods for antagonizing CD80 and/or CD86 interactions with CD28 in individuals, opening avenues for treating diseases or disorders linked to these interactions.

Career Highlights

Throughout his career, Christopher Plummer has been associated with several prominent companies, including Domantis Limited and Bristol-Myers Squibb Company. His work in these organizations has further solidified his reputation as a leading inventor in the pharmaceutical and biotechnology sectors.

Collaborations

Plummer has collaborated with notable individuals in his field, including Murray McKinnon and Steven G. Nadler. These partnerships have contributed to his innovative research and the development of patented technologies, underscoring the importance of collaboration in scientific advancement.

Conclusion

Christopher Plummer’s contributions to immunological therapeutics through his patents highlight the critical role of inventors in enhancing healthcare solutions. His innovative approaches in developing domain antibodies represent significant advancements that have the potential to impact clinical practices positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…